You are here
The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.
SBC: ALPHA-GAMMA TECHNOLOGIES, INC. Topic: CBD04113
DNA microarray technology, in combination with statistical and predictive modeling tools, could be used to evaluate thousands of genes against distinct gene expression patterns induced by chemical/biological agents to provide early identification and speed therapeutic intervention. The overall objective of this Phase II effort is to leverage existing public domain resources and commercial tools t ...SBIR Phase II 2005 Department of DefenseOffice for Chemical and Biological Defense
SBC: Nomadics, Inc. Topic: CBD04103
In Phase I, Nomadics demonstrated that a novel chemical weapon indicating chromophore (CWIC) developed by Professor Tim Swager at MIT will allow equipment to be quickly and easily examined to show any areas of contamination, making targeted decontamination manageable. When exposed to CW agent simulants, CWICs react to become fluorescent under UV stimulation. In the first phase, we implemented a s ...SBIR Phase II 2005 Department of DefenseOffice for Chemical and Biological Defense
SBC: SIGMA K CORP Topic: CBD04110
Effective collective protection fabrics must have a reliable closure system. During our Phase I Work Plan, Sigma-K began developing a Hermetic Textile Closure Hardware (HATCH) system. The HATCH combines both a magnetic and geometric self locking mechanism that will provide a hermetic seal when closed. Our current Phase I successes include developing self closing samples that can provide a hermetic ...SBIR Phase II 2005 Department of DefenseOffice for Chemical and Biological Defense